The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: Development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia

被引:39
|
作者
Skinner M.W. [1 ]
Chai-Adisaksopha C. [2 ,10 ]
Curtis R. [3 ]
Frick N. [4 ]
Nichol M. [5 ]
Noone D. [6 ]
O'Mahony B. [6 ,7 ]
Page D. [8 ]
Stonebraker J.S. [9 ]
Iorio A. [2 ,10 ]
机构
[1] Institute for Policy Advancement Ltd, 1155 23rd Street NW #3A, Washington, 20037, DC
[2] McMaster University, Department of Medicine, Hamilton
[3] Factor VIII Computing, Berkeley
[4] National Hemophilia Foundation, New York
[5] University of Southern California, Sol Price School of Public Policy, Los Angeles
[6] Irish Haemophilia Society, Dublin
[7] Trinity College Dublin, Dublin
[8] Canadian Hemophilia Society, Montreal
[9] North Carolina State University, Poole College of Management, Raleigh
[10] McMaster University, Department of Health Research Methods, Evidence, and Impact, Hamilton
关键词
Haemophilia; Patient-centered research; Patient-reported outcomes; Quality of life;
D O I
10.1186/s40814-018-0253-0
中图分类号
学科分类号
摘要
Background: The interest of health care agencies, private payers and policy makers for patient-reported outcomes (PRO) is continuously increasing. There is a substantial need to improve capacity to collect and interpret relevant PRO data to support implementation of patient-centered research and optimal care in haemophilia. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project aims to develop a patient-led research network, to develop a standardized questionnaire to gather patient-reported outcomes and to perform a feasibility study of implementing the PROBE questionnaire. Methods: A pilot questionnaire was developed using focus group methodology. Content and face validity were assessed by a pool of persons living with haemophilia (PWH) and content experts through interactive workshops. The PROBE questionnaire was translated with the forward-backward approach. PROBE recruited national haemophilia patient non-governmental organizations (NGOs) to administer the questionnaire to people with and without haemophilia. PROBE measured the time to complete the questionnaire and gathered feedback on its content and clarity; staff time and cost required to implement the questionnaire were also collected. Results: The PROBE questionnaire is comprised of four major sections (demographic data, general health problems, haemophilia-related health problems and health-related quality of life using EQ-5D-5L and EQ-VAS). Seventeen NGOs participated in the pilot study of the PROBE Project, recruiting 656 participants. Of these, 71% completed the questionnaire within 15 min, and all participants completed within 30 min. The median total staff and volunteer time required for the NGOs to carry out the study within their country was 9 h (range 2 to 40 h). NGO costs ranged from $22.00 to $543.00 USD per country, with printing and postage being the most commonly reported expenditures. Conclusions: The PROBE questionnaire assesses patient-important reported outcomes in PWH and control participants, with a demonstrated short completion time. PROBE proved the feasibility to engage diverse patient communities in the structured generation of real-world outcome research at all stages. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [11] Assessing the Value of Patient-Reported Outcomes
    Mitchell, Matthew
    AMERICAN HEALTH AND DRUG BENEFITS, 2013, 6 (04): : 274 - 274
  • [12] Use of Patient-Reported Outcomes for Assessing Diabetes Outcomes
    Kim, Hyon
    Shah, Kunal
    Buettner, Christoph
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (04) : 781 - 793
  • [13] Feasibility of integrating PROBE (patient reported outcomes, burdens and experiences) into a clinical care pathway to facilitate transformation to a value-based health care model in haemophilia
    Jackson, Shannon
    Sheridan, Barbara
    Gue, Deborah
    Lyons, Scott
    Waines, Rick
    Ireland, Tim
    Pete, Drashti
    Iorio, Alfonso
    Walsh, Leo
    Skinner, Mark
    Germini, Federico
    HAEMOPHILIA, 2022, 28 : 87 - 88
  • [14] Gene therapy with the Padua variant of a codon-optimised human factor IX gene etranacogene dezaparvovec in people with haemophilia B: Effects on patient-oriented outcomes measured using the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire in the HOPE-B study
    Pipe, Steven
    Abdelkader, Wael
    Clearfield, Elizabeth
    Kucher, Alexandra
    Joseph, Bernard
    Braverman, Julia
    Galante, Nicholas
    Monahan, Paul
    Ibrahim, Quazi
    Iorio, Alfonso
    Germini, Federico
    Skinner, Mark
    HAEMOPHILIA, 2024, 30 : 179 - 181
  • [15] PATIENT REPORTED OUTCOMES
    Schneider, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 21 - 21
  • [16] Patient reported outcomes
    Jenkinson, Crispin
    Morley, David
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2016, 15 (02) : 112 - 113
  • [17] Validation of the Achalasia Patient-Reported Outcomes Questionnaire
    Pandolfino, John E.
    Carlson, Dustin A.
    McGarva, Josie
    Kahrilas, Peter J.
    Vaezi, Michael
    Katzka, David
    Taft, Tiffany H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (10) : 1434 - 1443
  • [18] Measuring patient-reported outcomes in haemophilia clinical research
    Globe, D.
    Young, N. L.
    Von Mackensen, S.
    Bullinger, M.
    Wasserman, J.
    HAEMOPHILIA, 2009, 15 (04) : 843 - 852
  • [19] Evidence of a disability paradox in patient-reported outcomes in haemophilia
    O'Hara, Jamie
    Martin, Antony P.
    Nugent, Diane
    Witkop, Michelle
    Buckner, Tyler W.
    Skinner, Mark W.
    O'Mahony, Brian
    Mulhern, Brendan
    Morgan, George
    Li, Nanxin
    Sawyer, Eileen K.
    HAEMOPHILIA, 2021, 27 (02) : 245 - 252
  • [20] Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study
    Noone, D.
    Chai-Adisaksopha, C.
    Curtis, R.
    Frick, N.
    Nichol, M.
    O'Mahony, B.
    Page, D.
    Stonebraker, J.
    Iorio, A.
    Skinner, M. W.
    HAEMOPHILIA, 2018, 24 : 26 - 27